drugset / Trial / NCT01230138
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this trial is to investigate the efficacy and safety of different doses and dose administrations of FP187 compared to a placebo treatment in patients with moderate to severe plaque psoriasis.
Timeline
- Start
- 2010-09
- Primary completion
- 2012-01
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FP187 | Unknown | 250 mg | Oral |
| Subject | FP187 | Unknown | 375 mg | Oral |